FDA Publishes List of Drugs under Investigation
Below is a list of names of drugs that the FDA has provided in an effort to better inform medical doctors and their patients of concerns that have been raised with these drugs. For all of these drugs, the FDA has identified a potential safety issue. This does not mean that the FDA has established that the drug causes any harm or injury or that the potential risk of harm outweighs the drug’s potential benefits. Instead, it just means the FDA has identified that a drug may cause injury. The decision to take or stop taking a drug should be made in consultation with your doctor, not because the drug is on any list.
I’m a pretty big critic of the FDA but I think they are doing a good thing by offering information of concern with certain drugs but it a fair context. (Note: the release of the list comes after Congress last year ordered the FDA to produce a quarterly report of drugs being investigated by regulators. So maybe we should not spend too much time patting the FDA on the back.) Consumers have the right to know that which drugs are on the FDA’s watch list so that they can know to contact their doctor if they have a concern about a drug they are taking or a drug that a doctor has suggested that they initiate.
Some of these drugs are being explored for lawsuits by our products liability lawyers. For many others, our lawyers do not believe there is enough evidence to bring a claim. If would like to speak to a products liability lawyer about one of these drugs, either by phone or the Internet, call 800-553-8082 or click here for a free consultation or answer to your question.
Arginine Hydrochloride Injection (R-Gene 10): Pediatric overdose due to labeling / packaging confusion
Desflurane (Suprane): Cardiac arrest
Duloxetine (Cymbalta): Urinary retention
Etravirine (Intelence): Hemarthrosis
Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric):Adverse events due to name confusion
Heparin: Anaphylactic-type reactions
Icodextrin (Extraneal): Hypoglycemia
Insulin U-500 (Humulin R): Dosing confusion
Ivermectin (Stromectol) and Warfarin: Drug interaction
Lapatinib (Tykerb): Hepatotoxicity (chemical-driven liver damage)
Lenalidomide (Revlimid): Stevens Johnson Syndrome
Natalizumab (Tysabri): Skin melanomas
Nitroglycerin (Nitrostat): Overdose due to labeling confusion
Octreotide Acetate Depot (Sandostatin LAR): Ileus (partial or complete non-mechanical blockage of the small and/or large intestine)
Oxycodone Hydrochloride Controlled-Release (Oxycontin): Drug misuse, abuse and overdose
Perflutren Lipid Microsphere (Definity): Cardiopulmonary reactions
Phenytoin Injection (Dilantin) Purple Glove Syndrome (swollen extremities)
Quetiapine (Seroquel): Overdose due to sample pack labeling confusion (our lawyers believe problems with Seroquel may go well beyond the overdose problem)
Telbivudine (Tyzeka): Peripheral neuropathy
Tumor Necrosis Factor (TNF) Blockers: Cancers in children and young adults
